Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04770935
Status:
COMPLETED
Last Update Posted:
2023-04-28
First Post:
2021-02-22
Brief Title:
To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa BIVV001in Adults With Type 2N and 3 Von Willebrand Disease VWD
Sponsor:
Bioverativ a Sanofi company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
PKM16978
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bioverativ a Sanofi company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None